Talphera (NASDAQ:TLPH) Shares Down 2.7% – What’s Next?

Talphera, Inc. (NASDAQ:TLPH)’s share price was down 2.7% during mid-day trading on Monday . The company traded as low as $1.04 and last traded at $1.07. Approximately 189,221 shares were traded during trading, a decline of 55% from the average daily volume of 416,292 shares. The stock had previously closed at $1.10.

Analyst Ratings Changes

TLPH has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Talphera to a “hold” rating in a research report on Saturday, November 1st. Weiss Ratings restated a “sell (d-)” rating on shares of Talphera in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Talphera currently has an average rating of “Moderate Buy” and a consensus target price of $5.00.

Talphera Stock Up 5.6%

The company’s 50-day moving average is $1.23 and its 200-day moving average is $0.86. The stock has a market capitalization of $53.14 million, a price-to-earnings ratio of -3.00 and a beta of 0.25.

Talphera (NASDAQ:TLPH) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.01. Sell-side analysts anticipate that Talphera, Inc. will post -0.64 EPS for the current year.

Institutional Investors Weigh In On Talphera

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Nantahala Capital Management LLC raised its position in Talphera by 75.3% in the third quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after purchasing an additional 1,500,000 shares during the period. Virtu Financial LLC acquired a new stake in shares of Talphera during the 3rd quarter worth about $29,000. Dauntless Investment Group LLC purchased a new stake in Talphera in the 3rd quarter valued at about $89,000. Rosalind Advisors Inc. raised its holdings in Talphera by 118.9% in the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock valued at $3,917,000 after buying an additional 2,381,818 shares during the period. Finally, Group One Trading LLC lifted its position in Talphera by 3,224.0% in the third quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock valued at $27,000 after buying an additional 29,500 shares during the last quarter. Institutional investors and hedge funds own 37.67% of the company’s stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.